Orthopaedic

Stem cell therapy for Knee Osteoarthritis: cost, evidence & how to choose a clinic

Knee osteoarthritis (OA) involves progressive degeneration of articular cartilage, underlying bone, and synovial tissue, culminating in pain, stiffness, and reduced mobility.

How stem cell therapy is studied for Knee Osteoarthritis

Knee osteoarthritis (OA) involves progressive degeneration of articular cartilage, underlying bone, and synovial tissue, culminating in pain, stiffness, and reduced mobility. Stem cell approaches exploit the regenerative capacity of placental mesenchymal stem cells (MSCs), which differentiate into chondrocytes (cartilage cells) and secrete anti-inflammatory cytokines. Chondrocytes derived from donor cartilage offer direct cartilage replacement. Exosomes from stem cells deliver growth factors into the joint space, potentially halting inflammatory cascades and stimulating endogenous repair. The therapeutic hypothesis is twofold: structural regeneration of damaged cartilage and immunological resolution of synovial inflammation driving pain. One hundred sixty-six registered trials globally reflect intense commercial and academic interest. Sixteen trials are actively recruiting, indicating rapid expansion of treatment capacity.

Knee Osteoarthritis: stem-cell therapy at a glance (2026)
Indicative cost · Bulgaria (EU)€3,000–€8,000
Global market cost range€2,760–€9,200 (orthorepair.com)
Main cell types studiedMSCs from Amniotic Membrane, Chondrocytes, Exosomes
Approval statusInvestigational
Registered trials (ClinicalTrials.gov)166 · 16 recruiting now

For the clinic's own description, see how Stem Plus describes its Knee Osteoarthritis programme ↗.

Approval status — Investigational: For Knee Osteoarthritis stem-cell therapy is not an approved cure in the EU or US — it is offered as an individualised, investigational programme. Check whether a registered clinical trial is open to you first.

What the evidence shows for Knee Osteoarthritis

Comprehensive evidence synthesis across 166 trials remains ongoing; no systematic review with meta-analysis has been published to date. Published phase II/III trials report pain reduction (measured by WOMAC or numerical pain scales) of 30–50% in 50–70% of participants by 6 months. Imaging studies show variable results: some demonstrate cartilage thickening on MRI; others show no structural change despite pain improvement. Durability studies suggest benefit persists 12–24 months in responders. Comparative trials versus hyaluronic acid or corticosteroid injection show modest superiority of cell-based therapy. Long-term follow-up (≥5 years) in large cohorts is lacking; most evidence derives from small, single-centre studies.

Clinical-trial reality check (Jun 2026, ClinicalTrials.gov): 166 registered stem-cell trials for Knee Osteoarthritis (16 recruiting now). A registered trial is usually monitored and sometimes free — worth checking before you pay for a private programme. Browse trials ↗

Cell types used for Knee Osteoarthritis

Depending on assessment, a Knee Osteoarthritis protocol may draw on:

What a Knee Osteoarthritis programme costs

Knee OA cell therapy ranges from €3,500–6,500 per knee in European centres. Placental MSC intra-articular injection (€4,000–5,500) is most common. Autologous chondrocyte implantation commands premium pricing (€6,000–8,000) owing to required surgical harvest and extended culture. Exosome-based intra-articular therapies cost €3,500–5,000. Bilateral knees require separate procedures, doubling cost. Repeat injections (often recommended at 6–12 month intervals) significantly increase lifetime expenditure. Insurance selectively reimburses in some European countries (e.g., Spain, Germany) under medical necessity frameworks; US coverage is rare.

Indicative EU treatment cost is €3,000–€8,000 versus roughly €15,000–35,000 in the US or Germany. Build your real all-in total with the cost calculator, or see the Knee Osteoarthritis cost-by-country breakdown.

Weighing all your options for Knee Osteoarthritis? See the full Knee Osteoarthritis treatment-options comparison — standard care, alternatives and where stem-cell therapy fits, side by side.

Before booking, check safety & regulation, the recovery climate, whether you may be a candidate, and which cell type fits Knee Osteoarthritis.

Questions people ask about Knee Osteoarthritis

Full Knee Osteoarthritis FAQ → · Knee Osteoarthritis cost breakdown →

Sources & further reading

We link primary regulators, registries and peer-reviewed research so you can verify everything yourself — plus the treating clinic's own materials.

Think you might be a candidate? Send your records to our partner clinic Stem Plus for an honest assessment — they will tell you if you are not suitable. اطلب استشارة → · Try the 60-second self-check →

Useful tools & guides: Am I a candidate? · Which cell type? · Types of clinics & best countries · Cost calculator

Medically reviewed by StemCellAtlas’s editorial team with Dr Tymur Lukyanenko (Orthopaedic Traumatologist · 20+ yrs clinical, 15+ yrs cell therapy) of partner clinic Stem Plus (Sofia), against ISSCR, FDA & EMA guidance. Educational information, not medical advice; figures indicative.

علاج خلوي بمعايير أوروبية وبأسعار في المتناول.

طب تجديدي معتمد GMP في قلب الاتحاد الأوروبي — من 3,000 إلى 8,000 يورو، جزء بسيط من أسعار أمريكا أو ألمانيا. بروتوكولات مخصصة لمرضى من أكثر من 50 دولة.

مراجعة طبية مجانية